MELISSA

Mobile Artificial Intelligence Solution for Diabetes Adapted Care

Programm
Horizon Europe & sub-programmes
Laufzeit
60 Monate (June 2022 – May 2027)
Projektförderung
≈ €8 million
Projektpartner
12

Worum es geht

The MELISSA project, a collaboration of 12 partners from seven countries, aims to provide a clinically validated, effective, trustworthy, and cost-efficient artificial intelligence (AI)-based digital diabetes management solution to support both health care providers (HCPs) and insulin-treated patients with diabetes (PwD) in their daily routine with personalised treatment and care recommendations.

Koordination

Dr Bastiaan de Galan

Universiteit Maastricht

E-Mail senden

Ihre EURICE-Kontakte

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

THE COURT betreten